Kevin Berry had robotic surgery to remove his prostate in July 2024, but is still being treated as cancer cells had spread ...

Discover the role of commensal bacteria in the progression of prostate cancer and the potential treatment impacts.

AI-derived predictive biomarker identifies two thirds of patients with high-risk prostate cancer who may benefit from ...

BioZen Limited, a clinical-stage biotech company focussed on developing innovative treatments for endocrine disorders, today announced that the United Kingdom Patent Office has granted a new patent ...

It used to be that radiation therapy for prostate cancer involved weeks or months of repeat visits to a clinic for treatment.

Frailty assessments, particularly the G8 tool, BMI, and albumin, may identify mHSPC patients at higher risk for severe ...

The study investigators identified 24 prospective trials with 2,850 patients. The median patient age ranged between 59 and 77 years. Overall, testosterone recovery, defined at 240 ng/dL, was observed ...

It can take years for prostate cancer to turn castration-resistant, when cancer cells stop responding to hormonal therapy.

People live on average a little over two years after an mCRPC diagnosis. Find statistics here and learn how treatment ...

The investigators reported that treatment with darolutamide reduced the risk of radiological progression or death by 49% in ...

Sophia Kamran, MD, discusses how salvage therapy after biochemical recurrence may improve outcomes for patients with prostate ...

Lara Rodriguez Sanchez, Samir Taneja, Hashim Ahmed, Himanshu Nagar, Edward Schaeffer in a Crossfire: Controversies in Urology debate: discussed if Focal Therapy is a Suitable Option for all Cases with ...